Footprints of Stress in Vitiligo: Association of the 5-HTR2C rs6318 Variant

1 Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology. 2017;77(1):1-13. doi: https://doi.org/10.1016/j.jaad.2016.10.048 Search in Google Scholar

2 Khaled Ezzedine, Viktoria Eleftheriadou, Whitton M, Nanja van Geel. Vitiligo. The Lancet. 2015;386(9988):74-84. doi: https://doi.org/10.1016/S0140-6736(14)60763-7 Search in Google Scholar

3 Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clinical and Experimental Dermatology. 2010;35(7):736-739. doi: https://doi.org/10.1111/j.1365-2230.2009.03765.x Search in Google Scholar

4 Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. British Journal of Dermatology. 2009;161(1):134-139. doi: https://doi.org/10.1111/j.1365-2133.2009.09091.x Search in Google Scholar

5 Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology. 2012;51(10):1206-1212. doi: https://doi.org/10.1111/j.1365-4632.2011.05377.x Search in Google Scholar

6 Zhang Y, Cai Y, Shi M, et al. The Prevalence of Vitiligo: A Meta-Analysis. Oiso N, ed. PLOS ONE. 2016;11(9):e0163806. doi: https://doi.org/10.1371/journal.pone.0163806 Search in Google Scholar

7 Passeron T, Ortonne JP. Vitiligo and other disorders of hypopigmentation. Dermatology. 4th ed. ELSEVIER. 2018;1087-95 Search in Google Scholar

8 Reichert Faria A, Tarlé RG, Dellatorre G, Mira MT, Silva de Castro CC. Vitiligo - Part 2 - classification, histopathology and treatment. Anais Brasileiros de Dermatologia. 2014;89(5):784-790. doi: https://doi.org/10.1590/abd1806-4841.20142717 Search in Google Scholar

9 Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell & Melanoma Research. 2012;25(3):E1-E13. doi: https://doi.org/10.1111/j.1755-148x.2012.00997.x Search in Google Scholar

10 Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clinical Reviews in Allergy & Immunology. 2017;54(1):52-67. doi: https://doi.org/10.1007/s12016-017-8622-7 Search in Google Scholar

11 Kubelis-López D, Zapata-Salazar N, Said-Fernández S, et al. Updates and new medical treatments for vitiligo (Review). Experimental and Therapeutic Medicine. 2021;22(2). doi: https://doi.org/10.3892/etm.2021.10229 Search in Google Scholar

12 Malakar S, Dhar S. Spontaneous repigmentation of vitiligo patches distant from the autologous skin graft sites: a remote reverse Koebner’s phenomenon?. Dermatology (Basel, Switzerland). 1998;197(3):274. Search in Google Scholar

13 Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta‐analysis of observational studies. British Journal of Dermatology. 2017;177(3):708-718. doi: https://doi.org/10.1111/bjd.15199 Search in Google Scholar

14 Heisler LK, Pronchuk N, Nonogaki K, et al. Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation. Journal of Neuroscience. 2007;27(26):6956-6964. doi: https://doi.org/10.1523/jneurosci.2584-06.2007 Search in Google Scholar

15 Lappalainen J, Zhang L, Dean M, et al. Identification, Expression, and Pharmacology of a Cys23-Ser23 Substitution in the Human 5-HT2C Receptor Gene (HTR2C). Genomics. 1995;27(2):274-279. doi: https://doi.org/10.1006/geno.1995.1042 Search in Google Scholar

16 Brummett BH, Babyak MA, Williams RB, et al. A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress. Walss-Bass C, ed. PLoS ONE. 2014;9(12):e114451. doi: https://doi.org/10.1371/journal.pone.0114451 Search in Google Scholar

17 Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S. 5-HT2A and 5-HT2C Receptor Polymorphisms and Psychopathology in Late Onset Alzheimer’s Disease. Human Molecular Genetics. 1998;7(9):1507-1509. doi: https://doi.org/10.1093/hmg/7.9.1507 Search in Google Scholar

18 Holmes C, Arranz M, Collier D, Powell J, Lovestone S. Depression in Alzheimer’s disease: The effect of serotonin receptor gene variation. American Journal of Medical Genetics. 2003;119B(1):40-43. doi: https://doi.org/10.1002/ajmg.b.10068 Search in Google Scholar

19 Brummett BH, Babyak MA, Jiang R, et al. A Functional Polymorphism in the 5HTR2C Gene Associated with Stress Responses Also Predicts Incident Cardiovascular Events. Ahuja SK, ed. PLoS ONE. 2013;8(12):e82781. doi: https://doi.org/10.1371/journal.pone.0082781 Search in Google Scholar

20 Temel SG, Ergoren MC, Yilmaz I, Yuruker O, Cobanogullari H, Tosun O, et al. Association of the 5HT-R2C gene Ser23 variation with childhood allergic asthma. The Euro-Biotech Journal. 2022 Jul 1;6(3):126-32. Search in Google Scholar

21 Temel SG, Yazici S, Yilmaz İ, et al. Psoriasis and 5HTR2C Gene Polymorphism: Association between Clinical, Demographic and Therapeutic Parameters in the Turkish Population. Acta dermatovenerologica Croatica: ADC. 2021;29(3):121-126. Accessed November 10, 2023. https://pubmed.ncbi.nlm.nih.gov/34990340/ Search in Google Scholar

22 Enkhtaivan E, Lee CH. Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication. International Journal of Molecular Sciences. 2021;22(15):8071. doi: https://doi.org/10.3390/ijms2215807121. Search in Google Scholar

23 Gerritsen SM, Akkerman JW, Nijmeijer B, Sixma JJ, Witkop CJ, White J. The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes. Scandinavian Journal of Haematology. 1977;18(3):249-256. Search in Google Scholar

24 Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. The British Journal of Dermatology. 2018;178(4):863-878. doi: https://doi.org/10.1111/bjd.1604923. Search in Google Scholar

25 Nicolaidou E, Antoniou C, Miniati A, et al. Childhood-and later-onset vitiligo have diverse epidemiologic and clinical characteristics. Journal of the American Academy of Dermatology. 2012;66(6):954-958. doi: https://doi.org/10.1016/j.jaad.2011.07.01024. Search in Google Scholar

26 Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening. BioMed Research International. 2016;2016(8065765):1-5. doi: https://doi.org/10.1155/2016/806576525. Search in Google Scholar

27 Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. Journal of the European Academy of Dermatology and Venereology. 2007;21(7):921-928. doi: https://doi.org/10.1111/j.1468-3083.2006.02106.x Search in Google Scholar

28 Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clinical and Experimental Dermatology. 1998;23(6):243-248. doi: https://doi.org/10.1046/j.1365-2230.1998.00384.x Search in Google Scholar

29 Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95(5):255-262. https://pubmed.ncbi.nlm.nih.gov/26057504/ Search in Google Scholar

30 Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmunity reviews. 2008;7(3):209-213. doi: https://doi.org/10.1016/j.autrev.2007.11.00731. Search in Google Scholar

31 Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology (Basel, Switzerland). 1995;190(2):109-115. doi: https://doi.org/10.1159/000246657 Search in Google Scholar

32 TAÏEB A. Intrinsic and Extrinsic Pathomechanisms in Vitiligo. Pigment Cell Research. 2000;13:41-47. doi: https://doi.org/10.1034/j.1600-0749.13.s8.9.x Search in Google Scholar

33 Shalbaf M, Gibbons NCJ, Wood JM, et al. Presence of epidermal allantoin further supports oxidative stress in vitiligo. Experimental Dermatology. 2008;17(9):761-770. doi: https://doi.org/10.1111/j.1600-0625.2008.00697.x Search in Google Scholar

34 Schallreuter KU, Wood JM, Berger J. Low Catalase Levels in the Epidermis of Patients with Vitiligo. Journal of Investigative Dermatology. 1991;97(6):1081-1085. doi: https://doi.org/10.1111/1523-1747.ep12492612 Search in Google Scholar

35 Chiarella P. Vitiligo susceptibility at workplace and in daily life: the contribution of oxidative stress gene polymorphisms. Biomedical Dermatology. 2019;3(1). doi: https://doi.org/10.1186/s41702-019-0043-1 Search in Google Scholar

36 Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key role of CRF in the skin stress response system. Endocrine Reviews. 2013;34(6):827-884. doi: https://doi.org/10.1210/er.2012-1092 Search in Google Scholar

37 Nordlind K, Azmitia EC, Slominski A. The skin as a mirror of the soul: exploring the possible roles of serotonin. Experimental Dermatology. 2008;17(4):301-311. doi: https://doi.org/10.1111/j.1600-0625.2007.00670.x Search in Google Scholar

38 Kurbanov K, Berezov TT. [Tryptophan metabolism in vitiligo]. Voprosy Meditsinskoi Khimii. 1976;22(5):683-687. Accessed November 10, 2023. https://pubmed.ncbi.nlm.nih.gov/1014481/ Search in Google Scholar

39 Pang S, Wu H, Wang Q, Cai M, Shi W, Shang J. Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis. Slominski AT, ed. PLoS ONE. 2014;9(5):e98283. doi: https://doi.org/10.1371/journal.pone.0098283 Search in Google Scholar

40 Wu HL, Pang SL, Liu QZ, Wang Q, Cai MX, Shang J. 5-HT1A/1B Receptors as Targets for Optimizing Pigmentary Responses in C57BL/6 Mouse Skin to Stress. Slominski AT, ed. PLoS ONE. 2014;9(2):e89663. doi: https://doi.org/10.1371/journal.pone.0089663 Search in Google Scholar

41 Zhou L, Cai M, Ren Y, et al. The different roles of 5-HT1A/2A receptors in fluoxetine ameliorated pigmentation of C57BL/6 mouse skin in response to stress. Journal of Dermatological Science. 2018;92(3):222-229. doi: https://doi.org/10.1016/j.jdermsci.2018.10.002 Search in Google Scholar

42 Liu L, Fu M, Pei S, Zhou L, Shang J. R-Fluoxetine Increases Melanin Synthesis Through a 5-HT1A/2A Receptor and p38 MAPK Signaling Pathways. International Journal of Molecular Sciences. 2018;20(1):80-80. doi: https://doi.org/10.3390/ijms20010080 Search in Google Scholar

43 Lee HJ, Park MK, Kim SY, Park Choo HY, Lee AY, Lee CH. Serotonin induces melanogenesis via serotonin receptor 2A. British Journal of Dermatology. 2011;165(6):1344-1348. doi: https://doi.org/10.1111/j.1365-2133.2011.10490.x Search in Google Scholar

44 Luis Royo J. Hardy Weinberg Equilibrium Disturbances in Case-Control Studies Lead to Non-Conclusive Results. Cell Journal (Yakhteh). 2021;22(4):572-574. doi: https://doi.org/10.22074/cellj.2021.7195 Search in Google Scholar

45 Zhang X, Li L, Jiang L, et al. Characteristics and pathogenesis of Koebner phenomenon. Experimental Dermatology. 2022;32(4):310-323. doi: https://doi.org/10.1111/exd.14709 Search in Google Scholar